Who is Abridge’s CEO Shiv Rao? No, Really…

Posted Wednesday, September 23, 2026 12:07 pm

Arundhati Parmar (via MedCity News)

At the annual South Asian Health Leaders Forum held in Boston last week, Shiv Rao talked candidly about his biography and how it propelled him to build Abridge The post Who is Abridge’s CEO Shiv Rao? No, Really… appeared first on MedCity News.

Continue reading at MedCity News »

Keywords

Artificial Intelligence, Daily, Health Tech, Payers, Providers, Abridge, AI, Shiv Rao

Top stories

Ask About Clinical Trials on Day One

(Mitch Jelniker) - For people diagnosed with small cell lung cancer, the clinical trial conversation belongs in the very first appointment.A diagnosis of SCLC can trigger a whirlwind of appointments, …

From Uncertainty to Reassurance: How a Small Heart Monitor and Ablation Procedure Helped One Father Conquer the Unknowns of Atrial Fibrillation

(NewsUSA) - In 2018, then-52-year-old Todd Repass Jr. stood up after a meal and immediately knew something was wrong. It was terrifying. He felt weak, short of breath, and, at times, dizzy. The …

Youth Tobacco Use Is at Historic Lows. Adult Smokers Still Need Better Choices.

(Dr. Matthew Holman) - There is a piece of good public health news that deserves more attention: youth tobacco use in the United States has fallen to historically low levels. That progress did not …

America’s New Drug Dealers Have Moved from Street Corners to the Internet – and the FDA is Letting Them

(Peter Pitts, President and Co-founder of the Center for Medicine in the Public Interest ) - Consumers purchasing retatrutide online may think they are buying a safe, clinically tested weight-loss …

Hear from a prostate cancer patient about the one test more men should ask for

(Novartis) - Dr. Koo, EVP and CMO at Prostate Cancer Foundation, and Bill, who is living with prostate cancer, answer some frequently asked questions about PSMA testing. Talk to your doctor and visit …

From the web

Sanofi Puts Up $1B to Expand Regeneron Alliance and Develop Next-Gen Dupixent

Sanofi and Regeneron Pharmaceuticals will collaborate on four next-generation antibody drugs that could offer advantages over Dupixent, the blockbuster immunology drug spawned by their R&D alliance. …

InvestorNewsBreaks – Beeline Holdings Inc. (NASDAQ: BLNE) Showcases Digital Mortgage Platform and New Paths to Homeownership

Beeline Holdings (NASDAQ: BLNE), a technology-driven mortgage lender and fractional equity platform, recently partnered with Emmy Award-winning Loft 100 Studios to produce a 45-minute …

'It's a nightmare.' Former refugee, professor on Trump's new Medicaid policy

Starting Oct. 1, many immigrants who are here legally lose their Medicaid coverage because of the Republican budget bill passed last year.

A new California law bans child marriage. What's the global outlook on the practice?

The governor of California has signed into law a ban on child marriage. What is the status of other efforts to ban the practice? And do bans prove effective?

AINewsBreaks – AZIO AI Holdings Inc. (NASDAQ: AZIO) Targets Infrastructure Bottleneck with Power-First Strategy

AZIO AI Holdings (NASDAQ: AZIO) was featured in a recent article that discussed its positioning as an integrated AI compute infrastructure company focused on addressing a growing constraint on AI …

Who is Abridge’s CEO Shiv Rao? No, Really…

Keywords

Sanofi Puts Up $1B to Expand Regeneron Alliance and …

InvestorNewsBreaks – Beeline Holdings Inc. (NASDAQ: …

'It's a nightmare.' Former refugee, professor on …

A new California law bans child marriage. What's the …